An excipient from Trigonella foenum-graceum seeds and a process for preparation thereof is disclosed. The excipient
obtained from Trigonella foenum-graceum seeds, comprising insoluble and soluble dietary fibers can be used in various phar
maceutical or cosmetic compositions and food, nutritional or dietary prepara...
The present invention discloses compositions comprising fenugreek hydrocolloids comprising soluble and insoluble dietary fibers. The present invention further relates to the use of these compositions comprising fenugreek hydrocolloids as healthcare, personal care, food, household care and industrial products.
...
The present invention relates to a novel dispersible tablet composition, which comprises of a pharmacologically active ingredient and at least one excipient, which reduces the sedimentation rate of active ingredient. This invention further relates to a process for the preparation of a dispersible tablet of a pharmac...
The present invention is directed to a pharmaceutical formulation of esketamine for nasal administration. The present invention further relates to pharmaceutical formulations of esketamine delivered through unit-dose nasal spray devices. The invention also relates to a process for the preparation of such a compositi...
The present invention relates to modified release formulations of levodopa. Particularly the invention relates to modified release formulation of levodopa that offers reduced dosing frequency.
[Class : 42] Providing Scientific And Industrial Research, Research And Development, Technical Research, Medical Clinics, Quality Control, Testing And Services, In Vitro Bioequivalence Studies And Services, Nasal And Inhalation Product Development Research And Services, Drug Device Performance Testing And Services.